• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective.

作者信息

Northup Patrick G, Davis Jessica P E

机构信息

Center for the Study of Coagulation in Liver Disease, Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, Virginia, USA.

出版信息

J Transl Int Med. 2018 Mar 28;6(1):1-5. doi: 10.2478/jtim-2018-0001. eCollection 2018 Mar.

DOI:10.2478/jtim-2018-0001
PMID:29607296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5874479/
Abstract
摘要

相似文献

1
Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective.肝硬化门静脉血栓形成的抗凝时机：一位美国肝病专家的观点
J Transl Int Med. 2018 Mar 28;6(1):1-5. doi: 10.2478/jtim-2018-0001. eCollection 2018 Mar.
2
Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.肝硬化患者门静脉血栓形成的治疗时机：一位德国肝病学家的观点
J Transl Int Med. 2018 Mar 28;6(1):11-15. doi: 10.2478/jtim-2018-0003. eCollection 2018 Mar.
3
Liver imaging. A hepatologist's perspective.肝脏影像学：肝病专家的视角
Clin Liver Dis. 2002 Feb;6(1):297-310, ix. doi: 10.1016/s1089-3261(03)00077-1.
4
Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.抗凝有利于肝硬化合并门静脉血栓患者血栓再通和生存：荟萃分析结果。
Adv Ther. 2021 Jan;38(1):495-520. doi: 10.1007/s12325-020-01550-4. Epub 2020 Nov 5.
5
Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective.布加综合征中经颈静脉肝内门体分流支架置入术的时机：一位英国肝病学家的观点
J Transl Int Med. 2018 Oct 9;6(3):97-104. doi: 10.2478/jtim-2018-0022. eCollection 2018 Sep.
6
[Complexities and challenges in the management of portal vein thrombosis in cirrhosis].[肝硬化门静脉血栓形成管理中的复杂性与挑战]
Zhonghua Gan Zang Bing Za Zhi. 2021 Mar 20;29(3):196-198. doi: 10.3760/cma.j.cn501113-20210127-00046.
7
Management of portal vein thrombosis in liver cirrhosis.肝硬化门静脉血栓形成的处理。
Nat Rev Gastroenterol Hepatol. 2014 Jul;11(7):435-46. doi: 10.1038/nrgastro.2014.36. Epub 2014 Apr 1.
8
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.非肿瘤性门静脉血栓形成：肝硬化的一个具有挑战性的后果。
J Clin Transl Hepatol. 2020 Dec 28;8(4):432-444. doi: 10.14218/JCTH.2020.00067. Epub 2020 Nov 11.
9
Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.肝硬化和门静脉血栓形成的抗凝治疗是安全的，并可改善晚期肝硬化的预后。
Dig Dis Sci. 2019 Sep;64(9):2671-2683. doi: 10.1007/s10620-019-05572-z. Epub 2019 Mar 9.
10
Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding.肝硬化门静脉血栓形成合并急性静脉曲张出血患者的急诊抗凝治疗
Scand J Gastroenterol. 2012 Jun;47(6):686-91. doi: 10.3109/00365521.2012.674972. Epub 2012 Apr 4.

引用本文的文献

1
Fibrin clot properties and thrombus composition in cirrhosis.肝硬化患者的纤维蛋白凝块特性与血栓组成
Res Pract Thromb Haemost. 2023 Jan 20;7(1):100055. doi: 10.1016/j.rpth.2023.100055. eCollection 2023 Jan.

本文引用的文献

1
Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.肝硬化和门静脉血栓形成患者抗凝剂的有害和有益作用。
Clin Gastroenterol Hepatol. 2018 Jul;16(7):1146-1152.e4. doi: 10.1016/j.cgh.2017.10.016. Epub 2017 Oct 21.
2
Techniques and long-term effects of transjugular intrahepatic portosystemic shunt on liver cirrhosis-related thrombotic total occlusion of main portal vein.经颈静脉肝内门体分流术治疗肝硬化相关主门静脉血栓性完全闭塞的技术及长期效果。
Sci Rep. 2017 Sep 7;7(1):10868. doi: 10.1038/s41598-017-11455-y.
3
Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward.肝硬化患者肝移植中直接口服抗凝剂的逆转：向前迈进的一步。
Liver Transpl. 2017 Mar;23(3):396-397. doi: 10.1002/lt.24708.
4
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.肝硬化门静脉高压出血：风险分层、诊断及管理：美国肝病研究协会2016年实践指南
Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1.
5
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.内脏静脉血栓形成和肝硬化患者使用直接口服抗凝剂的抗栓治疗
Liver Int. 2017 May;37(5):694-699. doi: 10.1111/liv.13285. Epub 2016 Nov 19.
6
Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients With Cirrhosis.肝硬化患者门静脉血栓形成的全面新分类研究
Gastroenterology. 2016 Oct;151(4):574-577.e3. doi: 10.1053/j.gastro.2016.08.033. Epub 2016 Aug 27.
7
Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.移植前门静脉血栓形成是肝移植受者因肝动脉血栓形成导致移植物丢失的独立危险因素。
HPB (Oxford). 2016 Mar;18(3):279-86. doi: 10.1016/j.hpb.2015.10.008. Epub 2015 Dec 10.
8
Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.门静脉再通及经颈静脉肝内门体分流术治疗慢性门静脉血栓形成：技术要点
Tech Vasc Interv Radiol. 2016 Mar;19(1):52-60. doi: 10.1053/j.tvir.2016.01.006. Epub 2016 Feb 6.
9
Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.与传统抗凝治疗相比，直接口服抗凝剂在肝硬化患者中引起出血的风险相似。
Dig Dis Sci. 2016 Jun;61(6):1721-7. doi: 10.1007/s10620-015-4012-2. Epub 2016 Jan 2.
10
Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.肝硬化门静脉血栓形成治疗的抗凝治疗：观察性研究的系统评价和荟萃分析
Eur J Intern Med. 2015 Jan;26(1):23-9. doi: 10.1016/j.ejim.2014.12.002. Epub 2015 Jan 5.